Michael W. Lutz

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks

  Acta Neuropathologica Communications · 2024-07-02 · 22 citations

• Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling

  Alzheimer s & Dementia Translational Research & Clinical Interventions · 2024-04-01 · 1 citations

• Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study

  The Journal of Prevention of Alzheimer s Disease · 2023-09-06 · 5 citations

• Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

  The Lancet Neurology · 2021-06-16 · 117 citations

• TOMM40‐APOE haplotypes are associated with cognitive decline in non‐demented Blacks

  Alzheimer s & Dementia · 2021-02-13 · 19 citations

• TOMM40‐APOE haplotypes are associated with cognitive decline in non‐demented blacks

  Alzheimer s & Dementia · 2020-12-01